Sionna Therapeutics, Inc. (SION) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 2 Buy, 1 Sell.
The consensus price target is $46.25 (low: $24.00, high: $58.00), representing an upside of 2.6% from the current price $45.09.
Analysts estimate Earnings Per Share (EPS) of $-5.26 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.45 vs est $-5.26 (beat +72.5%). 2025: actual $-1.88 vs est $-2.00 (beat +5.8%). Analyst accuracy: 0%.
SION Stock — 12-Month Price Forecast
$46.25
▲ +2.57% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Sionna Therapeutics, Inc., the average price target is $46.25, with a high forecast of $58.00, and a low forecast of $24.00.
The average price target represents a +2.57% change from the last price of $45.09.
Highest Price Target
$58.00
Average Price Target
$46.25
Lowest Price Target
$24.00
SION Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to Sionna Therapeutics, Inc. in the past 3 months
EPS Estimates — SION
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.45
vs Est –$5.26
▲ 263.0% off
2025
Actual –$1.88
vs Est –$2.00
▲ 6.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — SION
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
